Advanced dry AMD is characterized by atrophy of the retina, leading to partial retinal detachment, while wet AMD is characterized by abnormal angiogenesis and is therefore treated with anti-VEGF drugs that inhibit the action of vascular endothelial growth factor (VEGF). The gene discussed is VEGFA; the disease is dry age related macular degeneration.